alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Environmental Monitoring Documents

Last Modified: 

Print

All links on this page are in Portable Document Format (PDF).

Environmental Monitoring Plans

Asian Longhorned Beetle

2015 Environmental Monitoring Plan

2013 Environmental Monitoring Plan - Boston and Worcester, Massachusetts

2012 Environmental Monitoring Plan - Boston and Worcester, Massachusetts

2011 Environmental Monitoring Plan - Boston and Worcester, Massachusetts

2010 Environmental Monitoring Plan - Worcester, Massachusetts

Boll Weevil

2016 Environmental Monitoring Plan - Texas

2013 Environmental Monitoring Plan - Texas

2012 Environmental Monitoring Plan - Texas

2011 Environmental Monitoring Plan - Texas

2010 Environmental Monitoring Plan - Texas

2009 Environmental Monitoring Plan - Arkansas, Louisiana, Missouri, and

Tennessee

2009 Environmental Monitoring Plan - New Mexico, Oklahoma, and Texas
2008 Environmental Monitoring Plan - Arkansas, Louisiana, Missouri, and

Tennessee

2008 Environmental Monitoring Plan - New Mexico, Oklahoma, and Texas

2007 Environmental Monitoring Plan - Arkansas, Louisiana, Mississippi, Missouri,

and Tennessee

2007 Environmental Monitoring Plan - New Mexico, Oklahoma, and Texas

Fruit Fly

2011 Environmental Monitoring Plan - Pompano Beach, Florida

2010 Environmental Monitoring Plan - Boca Raton, Florida

Pink Bollworm

2007 Environmental Monitoring Plan - Arizona, New Mexico, and Texas

Rangeland Grasshopper and Mormon Cricket

2012 Environmental Monitoring Plan

2011 Environmental Monitoring Plan

2010 Environmental Monitoring Plan

2009 Environmental Monitoring Plan

2008 Environmental Monitoring Plan

2007 Environmental Monitoring Plan

Standard Operating Procedures

Collection of Dye Card Samples

Collection of Groundwater Samples

Collection of Insect Samples

Collection of  Sediment Samples

Collection of Soil Samples

Collection of Vegetation Samples

Collection of Water Samples

Guidelines for Selecting Environmental Monitoring Sites

Measurement of Dissolved Oxygen in Water Samples

Observing Bald Eagles at Nest Sites

Packaging and Shipping of Samples

Preparation of Control Samples and Collection of Pesticide Samples
Priority (Emergency) Sampling

Sensitive Site Selection Worksheet

Taking Measurements for the APHIS Form 2060

Using a Field Log Book

Other Guidance Documents

National Bald Eagle Management Guidelines
# C_2023045EN.01003504.xml

| 6.2.2023 | EN | Official Journal of the European Union | C 45/35 |
| --- | --- | --- | --- |

6.2.2023

EN

Official Journal of the European Union

C 45/35

---

Order of the General Court of 30 November 2022 — Buffalo — Boots v Commission

(Case T-142/18) (1)

(2023/C 45/55)

Language of the case: English

The President of the Sixth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 152, 30.4.2018.

---
#### Smyth v. Pacific Int'l Holdings, Inc.

16271

9/28/94

Reversed and Remanded
# C_2019363EN.01001402.xml

| 28.10.2019 | EN | Official Journal of the European Union | C 363/14 |
| --- | --- | --- | --- |

28.10.2019

EN

Official Journal of the European Union

C 363/14

---

Order of the General Court of 9 September 2019 — Shore Capital International v EUIPO — Circle Imperium (The Inner Circle)

(Case T-575/18) (1)

(EU trade mark - Opposition proceedings - International registration designating the European Union - Figurative mark The Inner Circle - Earlier EU word mark InnerCircle - Relative ground for refusal - No similarity between the services - Article 8(1)(b) of Regulation (EU) 2017/1001 - Action manifestly lacking any foundation in law)

(2019/C 363/21)

Language of the case: English

Parties

Applicant: Shore Capital International Ltd (Berlin, Germany) (represented by: O. Spieker, A. Schönfleisch and N. Willich, lawyers)

Defendant: European Union Intellectual Property Office (represented by: L. Rampini and H. O’Neill, Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: Circle Imperium BV (Amsterdam, Netherlands)

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 7 June 2018 (Case R 1402/2017-1), relating to opposition proceedings between Shore Capital International and Circle Imperium.

Operative part of the order

| 1. | The action is dismissed. |
| --- | --- |

1.

The action is dismissed.

| 2. | Shore Capital International Ltd shall pay the costs. |
| --- | --- |

2.

Shore Capital International Ltd shall pay the costs.

---

(1)  OJ C 427, 26.11.2018.

---
#### Fong v. Utne

21501

12/16/98

Dismissed
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2023-N-3859]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice; correction.

# SUMMARY:

                        The Food and Drug Administration (FDA) is correcting a notice that appeared in the                         **Federal Register**                         on October 4, 2023. The document announced the withdrawal of approval of 11 abbreviated new drug applications (ANDAs) from Dr. Reddy's Laboratories, Inc., withdrawn as of November 3, 2023. The document indicated that FDA was withdrawing approval of ANDA 203807, clozapine tablets, 25 milligrams (mg), 50 mg, 100 mg, and 200 mg, held by Dr. Reddy's Laboratories, Inc., U.S. Agent for Dr. Reddy's Laboratories SA, 107 College Rd. East, Princeton, NJ 08540. Before FDA withdrew the approval of this ANDA, Dr. Reddy's Laboratories, Inc., informed FDA that it did not want the approval of the ANDA withdrawn. Because Dr. Reddy's Laboratories, Inc., timely requested that approval of ANDA 203807 not be withdrawn, the approval is still in effect. This notice corrects that error.                    

# FOR FURTHER INFORMATION CONTACT:

                        Martha Nguyen, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 75, Rm. 1676, Silver Spring, MD 20993-0002, 240-402-6980,                         *Martha.Nguyen@fda.hhs.gov.*

# SUPPLEMENTARY INFORMATION:

                    In the                     **Federal Register**                     of Wednesday, October 4, 2023 (88 FR 68628), appearing on                           ( print page 85629)                        page 68629 in FR Doc. 2023-21992, the following correction is made:                

On page 68629, in the table, the entry for ANDA 203807 is removed.

Dated: December 5, 2023.

Lauren K. Roth,

Associate Commissioner for Policy.

[FR Doc. 2023-26994 Filed 12-7-23; 8:45 am]

BILLING CODE 4164-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000880114
<NAME> BELDEN & BLAKE CORPORATION
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           8,225
<SECURITIES>                                         0
<RECEIVABLES>                                   32,256
<ALLOWANCES>                                         0
<INVENTORY>                                     12,973
<CURRENT-ASSETS>                                61,141
<PP&E>                                         571,580
<DEPRECIATION>                                  64,391
<TOTAL-ASSETS>                                 593,637
<CURRENT-LIABILITIES>                           39,117
<BONDS>                                        371,145
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,011
<OTHER-SE>                                      82,303
<TOTAL-LIABILITY-AND-EQUITY>                   593,637
<SALES>                                         76,740
<TOTAL-REVENUES>                                78,501
<CGS>                                           41,708
<TOTAL-COSTS>                                   41,708
<OTHER-EXPENSES>                                42,923
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              16,179
<INCOME-PRETAX>                               (22,309)
<INCOME-TAX>                                   (7,808)
<INCOME-CONTINUING>                           (14,501)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (14,501)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
June 20, 2002

24386

#### Doe, In re

Affirmed
19102

#### State v. Pawn

January 31, 1997

Order No. 97-10

Vacated in part. Granted in part
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 742 Engrossed in House (EH)]

<DOC>
H. Res. 742

                In the House of Representatives, U. S.,

                                                          May 24, 2016.
    Resolved, That upon adoption of this resolution it shall be in order to take 
from the Speaker's table the bill (H.R. 2576) to modernize the Toxic Substances 
Control Act, and for other purposes, with the Senate amendment thereto, and to 
consider in the House, without intervention of any point of order, a motion 
offered by the chair of the Committee on Energy and Commerce or his designee 
that the House concur in the Senate amendment with an amendment inserting the 
text of Rules Committee Print 114-54 modified by the amendment printed in the 
report of the Committee on Rules accompanying this resolution in lieu of the 
matter proposed to be inserted by the Senate. The Senate amendment and the 
motion shall be considered as read. The motion shall be debatable for one hour 
equally divided and controlled by the chair and ranking minority member of the 
Committee on Energy and Commerce. The previous question shall be considered as 
ordered on the motion to its adoption without intervening motion or demand for 
division of the question.
    Sec. 2.  Upon adoption of this resolution it shall be in order to consider 
in the House the bill (H.R. 897) to amend the Federal Insecticide, Fungicide, 
and Rodenticide Act and the Federal Water Pollution Control Act to clarify 
Congressional intent regarding the regulation of the use of pesticides in or 
near navigable waters, and for other purposes. All points of order against 
consideration of the bill are waived. An amendment in the nature of a substitute 
consisting of the text of Rules Committee Print 114-53 shall be considered as 
adopted. The bill, as amended, shall be considered as read. All points of order 
against provisions in the bill, as amended, are waived. The previous question 
shall be considered as ordered on the bill, as amended, and on any further 
amendment thereto, to final passage without intervening motion except: (1) one 
hour of debate equally divided and controlled by the chair and ranking minority 
member of the Committee on Transportation and Infrastructure; and (2) one motion 
to recommit with or without instructions.
            Attest:

                                                                          Clerk.
```
EXHIBIT 32.0




                      DIRECT INSITE CORP. AND SUBSIDIARIES

                        CERTIFICATION OF PERIODIC REPORT






I, James A.  Cannavino,  Chief  Executive  Officer of Direct  Insite Corp.  (the
"Company"),  certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
18 U.S.C. Section 1350, that::

(1)  The  Quarterly  Report  on Form 10-Q of the  Company  for the three and six
     months  ended  June  30,  2008  (the  "Report"),  fully  complies  with the
     requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of
     1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of the Company.



Date: August 13, 2008





                                      /s/James A. Cannavino
                                      -----------------------
                                      James A. Cannavino
                                      Chief Executive Officer



<PAGE>






                      DIRECT INSITE CORP. AND SUBSIDIARIES

                        CERTIFICATION OF PERIODIC REPORT






I, Michael J.  Beecher,  Chief  Financial  Officer of Direct  Insite Corp.  (the
"Company"),  certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
18 U.S.C. Section 1350, that::

(1)  The  Quarterly  Report  on Form 10-Q of the  Company  for the three and six
     months  ended  June  30,  2008  (the  "Report"),  fully  complies  with the
     requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of
     1934); and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of the Company.


Date: August 13, 2008
                                      /s/ Michael J. Beecher
                                      ----------------------
                                      Michael J. Beecher
                                      Chief Financial Officer
Item_5_3_12a_Q fever/ page 1

Annex 24

CHAPTER 8.X.INFECTION WITH *COXIELLA**BURNETII* (Q FEVER)

Article 8.X.1.

General provisions

Various animal species and humans can be affected by Q fever. For the purposes of the *Terrestrial Code*, Q fever is defined as an *infection* of domestic and *captive wild* ruminants, dogs, and cats (hereafter ‘susceptible animal’) with *Coxiella burnetii*. 

The following defines the occurrence of *infection* with *C. burnetii*:

1)	*C. burnetii* has been isolated and identified as such in a sample from a susceptible animal; or 

2)	nucleic acid specific to *C. burnetii* has been detected in a sample from a susceptible animal that is epidemiologically linked to a confirmed or suspected *case*; or

3)	antibodies specific to *C. burnetii*, that are not the consequence of *vaccination*, have been detected in a sample from a susceptible animal that is epidemiologically linked to a confirmed or suspected *case*.

Standards for diagnostic tests and vaccines are described in the *Terrestrial Manual*. 

___________________________

*WOAH Terrestrial Animal Health Standards Commission/September 2022*

*WOAH Terrestrial Animal Health Standards Commission/September 2022*1
AFS-14-115-E 

March 14, 2014 

 Exemption No. 10504A 

 Regulatory Docket No. FAA-2012-0373 

Ms. Dawn Moeller 

Parent of Tyler Moeller 

8 Captolene Avenue 

Bloomingdale, NJ 07403 

Dear Ms. Moeller: 

This letter is to inform you that we have granted your petition to extend Exemption 

No. 10504. It explains the basis for our decision, describes its effect, and lists the conditions 

and limitations. 

The Basis for Our Decision 

By letters dated January 16, 2014 and February 13, 2014, you petitioned the Federal Aviation 

Administration (FAA) on behalf of Tyler Moeller for an extension of Exemption No. 10504. 

That exemption from § 121.311(b) of Title 14, Code of Federal Regulations (14 CFR) allows 

Tyler to exceed the specified weight limit for an FAA-approved child restraint system 

(CAReS, manufactured by AmSafe Corporation) during use of that child restraint system 

(CRS) aboard a United States (U.S.) aircraft. 

In your petition, you indicate that there has been no change in the conditions and reasons 

relative to public interest and safety that were the basis for granting the original exemption. 

The FAA has determined that good cause exists for not publishing a summary of the petition 

in the Federal Register because the requested extension of the exemption would not set a 

precedent, and any delay in acting on this petition would be detrimental to Tyler. 
 2

Our Decision 

The FAA has determined that the justification for the issuance of Exemption No. 10504 

remains valid with respect to this exemption and is in the public interest. Therefore, under the 

authority provided by 49 U.S.C. §§ 106(f), 40113, and 44701, I hereby grant Tyler Moeller an 

extension to the exemption from § 121.311(b). Any air carrier or commercial operator 

operating under part 121 while Tyler is aboard its aircraft is granted an exemption from 14 

CFR § 121.311(b) to the extent necessary to allow him to use an FAA-approved CRS aboard 

a U.S. aircraft. 

All operations under this exemption must be conducted with at least one of Tyler’s parents or 

a caregiver accompanying him. Tyler Moeller may only occupy a passenger seat with no 

passenger seated behind him. In addition, Tyler’s parent or caregiver must carry a copy of 

this exemption and advise the air carrier about the contents of the exemption at least 48 hours 

before the date of each flight. 

Our decision extends the termination date of Exemption No. 10504 to April 30, 2019, unless 

sooner superseded or rescinded. 

Sincerely, 

/s/ 

John Barbagallo 

Acting Deputy Director, Flight Standards Service
#### State v. Frank

23808

02/28/2002

Affirmed
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 751 Engrossed in House (EH)]

<DOC>
H. Res. 751

                In the House of Representatives, U. S.,

                                                          May 26, 2016.
    Resolved, That upon adoption of this resolution--
     (a) the House hereby takes from the Speaker's table the bill (H.R. 2577) 
making appropriations for the Departments of Transportation, and Housing and 
Urban Development, and related agencies for the fiscal year ending September 30, 
2016, and for other purposes, with the Senate amendment thereto, and concurs in 
the Senate amendment with an amendment consisting of the text of Rules Committee 
Print 114-56; and
    (b) it shall be in order for the chair of the Committee on Appropriations or 
his designee to move that the House insist on its amendment to the Senate 
amendment to H.R. 2577 and request a conference with the Senate thereon.
            Attest:

                                                                          Clerk.
```
<PAGE>

EXHIBIT 32


   CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND ACTING CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the annual report on Form 10-K of Emrise Corporation
(the "Company") for the year ended December 31, 2004 (the "Report"), the
undersigned hereby certify in their capacities as Chief Executive Officer and
Acting Chief Financial Officer of the Company, respectively, pursuant to 18
U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

         1. the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

         2. the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: April 5, 2005                         By: /s/ CARMINE T. OLIVA
                                                 ------------------------------
                                                 Carmine T. Oliva
                                                 Chief Executive Officer
                                                 (principal executive officer)


Dated: April 5, 2005                         By: /s/ CARMINE T. OLIVA
                                                 ------------------------------
                                                 Carmine T. Oliva
                                                 Acting Chief Financial Officer
                                                 (principal financial officer)

         A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signatures that appear in typed form within the electronic version of this
written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
# C_2019295EN.01000201.xml

| 2.9.2019 | EN | Official Journal of the European Union | C 295/2 |
| --- | --- | --- | --- |

2.9.2019

EN

Official Journal of the European Union

C 295/2

---

Request for a preliminary ruling from the Općinski građanski sud u Zagrebu — Stalna služba u Sesvetama (Croatia) lodged on 30 July 2018 and 15 January 2019 — QB, RA v Jadransko osiguranje d.d

(Case C-651/18)

(2019/C 295/02)

Language of the case: Croatian

Referring court

Općinski građanski sud u Zagrebu — Stalna služba u Sesvetama

Parties to the main proceedings

Applicants: QB, RA

Defendant: Jadransko osiguranje d.d

By order of 11 July 2019, the Court of Justice (Ninth Chamber) declared that the request for a preliminary ruling made by the Općinski građanski sud u Zagrebu (Municipal Civil Court, Zagreb), by decisions of 30 July 2018 and 15 January 2019, is manifestly inadmissible.

---
20747

#### State v. Kwan

Affirmed
Order entered May 6, 2022

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-22-00388-CV

IN THE INTEREST OF K.G.R., A CHILD

On Appeal from the 354th Judicial District Court

Hunt County, Texas

Trial Court Cause No. 90189

ORDER

Before the Court is the May 5, 2022 request of Shannon Sudderth, Official 

Court Reporter for the 354th Judicial Court for a five-day extension of time to file 

the reporter’s record in this accelerated appeal involving the termination of 

parental rights. We GRANT the request and extend the time to May 10, 2022. 

/s/ BONNIE LEE GOLDSTEIN

JUSTICE
p.1 

OAR Box 1834 

Prepped by Keeia Richards 

Document Number: 

3DIV-E-04 

Docket Number: 

A-90-07 

Printed 11/10/2008 2:14:34 PM Sheet 31 of 61 
P.2 

Fuels/Fuel Additives Public Hearing 

Notice of Proposed Rulemaking 

Thursday, May 28, 1992 

List of Testifiers 

NAME 

Charles Keller 

Dr. John Sepesi 

Kenneth Whittet 

Philip Bush 

John Turkal 

COMPANY 

Chemical Manufacturers Assn 

American Petroleum Institute 

Solvall Engineering Co. 

Amoco Oil Company 

Aiken-Murray Corp.
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

KAMREN JECOREY GARTH, )

)

Appellant, )

)

v. ) Case No. 2D16-4669

)

STATE OF FLORIDA, )

)

Appellee. )

)

Opinion filed October 17, 2018. 

Appeal from the Circuit Court for 

Hillsborough County; Chet A. Tharpe, 

Judge.

Howard L. Dimmig, II, Public Defender, 

and Matthew J. Salvia, Assistant Public 

Defender, Bartow, for Appellant.

Pamela Jo Bondi, Attorney General, 

Tallahassee, and David Campbell, 

Assistant Attorney General, Tampa, for 

Appellee.

PER CURIAM.

Affirmed. 

MORRIS, BLACK, and LUCAS, JJ., Concur.